Jacobs Levy Equity Management Inc. Has $80.75 Million Holdings in Colgate-Palmolive (NYSE:CL)

Jacobs Levy Equity Management Inc. grew its position in Colgate-Palmolive (NYSE:CL) by 864.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 777,854 shares of the company’s stock after purchasing an additional 697,168 shares during the period. Jacobs Levy Equity Management Inc.’s holdings in Colgate-Palmolive were worth $80,749,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive in the second quarter valued at about $25,000. Continuum Advisory LLC grew its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Finally, Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the third quarter worth $64,000. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Stock Up 0.5 %

Shares of NYSE:CL opened at $97.10 on Tuesday. The company’s fifty day moving average is $97.38 and its 200-day moving average is $98.64. The company has a market capitalization of $79.33 billion, a PE ratio of 27.82, a P/E/G ratio of 3.45 and a beta of 0.43. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.06%. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of analyst reports. Piper Sandler started coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective on the stock. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. Finally, TD Cowen decreased their price target on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.